Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target-Reference-Cited by-同舟云学术

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Published:2022-04-28 Issue:8 Volume:18 Page:812-820
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Lechner Severin^ORCID,Malgapo Martin Ian P.,Grätz Christian^ORCID,Steimbach Raphael R.^ORCID,Baron Agnes,Rüther Patrick^ORCID,Nadal Simon^ORCID,Stumpf Carmen,Loos Christina,Ku Xin,Prokofeva Polina,Lautenbacher Ludwig^ORCID,Heimburg Tino,Würf Vivian^ORCID,Meng Chen,Wilhelm Mathias^ORCID,Sippl Wolfgang^ORCID,Kleigrewe Karin,Pauling Josch K.,Kramer Karl,Miller Aubry K.,Pfaffl Michael W.,Linder Maurine E.^ORCID,Kuster Bernhard^ORCID,Médard Guillaume^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41589-022-01015-5.pdf

Reference60 articles.

1. Bettica, P. et al. Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 26, 643–649 (2016).

2. Li, Y. & Seto, E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect. Med. 6, a026831 (2016).

3. Saito, M. et al. Acetylation of intrinsically disordered regions regulates phase separation. Nat. Chem. Biol. 15, 51–61 (2019).

4. Federspiel, J. D., Greco, T. M., Lum, K. K. & Cristea, I. M. Hdac4 interactions in Huntington’s disease viewed through the prism of multiomics. Mol. Cell. Proteomics 18, S92–S113 (2019).

5. Bardai, F. H. & D’Mello, S. R. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3β. J. Neurosci. 31, 1746–1751 (2011).

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting transposable elements and endogenous retroviruses upregulation by HDAC inhibitors in leiomyosarcoma cells: Implications for the interferon response;Genomics;2024-09

2. Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions;Frontiers in Molecular Neuroscience;2024-08-21

3. Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer;Journal of Medicinal Chemistry;2024-08-07

4. Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8;Journal of Medicinal Chemistry;2024-07-01

5. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27